Market Overview:
The global targeted RNA sequencing market is expected to grow at a CAGR of 16.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for personalized medicine, technological advancements in sequencing platforms and rising applications of RNA sequencing in various fields such as research institutes, hospitals & clinics, biotechnology companies and diagnostic labs. However, high cost of targeted RNA sequencing is expected to restrain the growth of this market during the forecast period. On the basis of type, enrichment approaches are anticipated to hold a larger share than amplicon-based approaches in terms of revenue by 2030 owing to their ability for detecting low abundance transcripts with high accuracy and specificity. By application, research institutes are estimated to account for a larger share than hospitals & clinics by 2030 due its growing demand for precision medicine and use in biomarker discovery studies.
Product Definition:
Targeted RNA sequencing is a technique that is used to sequence a specific region of RNA. This technique can be used to identify mutations in the RNA sequence. The importance of targeted RNA sequencing is that it can help identify mutations in the RNA sequence that may lead to disease.
enrichment approaches:
Enrichment approaches are procedures that are used to improve the quality and quantity of a particular type of RNA. It is done by using an enzyme, which will add a certain number of adenine or cytosine bases to the end of the nucleic acid chain. The process is then repeated until all libraries have been enriched in at least one segment, which can be used for sequencing.
amplicon-based approaches:
Amplicon-based approaches are used for the development of high-throughput sequencing methods. It is a set of techniques that involve the production and use of synthetic oligonucleotides as probes in a PCR-like reaction to detect and measure specific DNA sequences.
Application Insights:
Based on application, the global targeted RNA sequencing market has been segmented into research institutes, hospitals & clinics, biotechnology companies and diagnostic laboratories. Research Institutes held the largest share of over 60% in 2017. This is due to factors such as high usage rate of targeted RNA sequencing in research studies at present and increasing focus on personalized medicine by various governments across the world.
Hospitals & Clinics are expected to be one of the fastest-growing segments during forecast years owing to rising adoption rate for diagnostics purposes such as drug discovery and development programs. Moreover, hospitals & clinics are focusing more on precision health care which includes early diagnosis of diseases through advanced technologies like genomic analysis that aids in treatment planning thus driving demand for a targetedRNA sequencer usedin these settings.
Regional Analysis:
North America dominated the global market in 2017. This is due to the presence of a large number of research institutes and diagnostic laboratories that are engaged in R&D activities related to targeted sequencing. Moreover, these companies are collaborating with pharmaceutical companies for commercialization of their products at a relatively higher price. For instance, Pacific Biosciences has entered into collaboration with GlaxoSmithKline plc for development and commercialization of its TargetSelectmAb test kit used for detection of target RNA sequences in cancer cells.
Asia Pacific is expected to grow at an exponential rate during the forecast period owing to increasing prevalence rates associated with chronic diseases such as cancer and infectious diseases like HIV-1 which can be diagnosed using targeted sequencing techniques developed by Asian firms such as NGS Biotech Co., Ltd., Sinomics Corporation Limited, etc.
Growth Factors:
- Increasing demand for personalized medicine
- Growing number of cancer patients
- Rising prevalence of genetic disorders
- Technological advancements in sequencing platforms and bioinformatics tools
- Growing investments in life sciences research
Scope Of The Report
Report Attributes
Report Details
Report Title
Targeted RNA Sequencing Market Research Report
By Type
enrichment approaches, amplicon-based approaches
By Application
Research Institutes, Hospitals & Clinics, Biotechnology Company, Diagnostic Lab
By Companies
Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, LabCorp, Berry Genomics, Macrogen, GENEWIZ
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Targeted RNA Sequencing Market Report Segments:
The global Targeted RNA Sequencing market is segmented on the basis of:
Types
enrichment approaches, amplicon-based approaches
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research Institutes, Hospitals & Clinics, Biotechnology Company, Diagnostic Lab
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher
- Illumina
- Roche Holdings
- BGI
- Eurofins
- LabCorp
- Berry Genomics
- Macrogen
- GENEWIZ
Highlights of The Targeted RNA Sequencing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- enrichment approaches
- amplicon-based approaches
- By Application:
- Research Institutes
- Hospitals & Clinics
- Biotechnology Company
- Diagnostic Lab
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Targeted RNA Sequencing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Targeted RNA sequencing is a method of sequencing large numbers of individual RNAs from a sample. This allows researchers to identify specific genes or sequences within the RNAs.
Some of the key players operating in the targeted rna sequencing market are Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, LabCorp, Berry Genomics, Macrogen, GENEWIZ.
The targeted rna sequencing market is expected to grow at a compound annual growth rate of 16.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Targeted RNA Sequencing Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Targeted RNA Sequencing Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Targeted RNA Sequencing Market - Supply Chain
4.5. Global Targeted RNA Sequencing Market Forecast
4.5.1. Targeted RNA Sequencing Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Targeted RNA Sequencing Market Size (000 Units) and Y-o-Y Growth
4.5.3. Targeted RNA Sequencing Market Absolute $ Opportunity
5. Global Targeted RNA Sequencing Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Targeted RNA Sequencing Market Size and Volume Forecast by Type
5.3.1. enrichment approaches
5.3.2. amplicon-based approaches
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Targeted RNA Sequencing Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Targeted RNA Sequencing Market Size and Volume Forecast by Application
6.3.1. Research Institutes
6.3.2. Hospitals & Clinics
6.3.3. Biotechnology Company
6.3.4. Diagnostic Lab
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Targeted RNA Sequencing Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Targeted RNA Sequencing Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Targeted RNA Sequencing Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Targeted RNA Sequencing Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Targeted RNA Sequencing Demand Share Forecast, 2019-2026
9. North America Targeted RNA Sequencing Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Targeted RNA Sequencing Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Targeted RNA Sequencing Market Size and Volume Forecast by Application
9.4.1. Research Institutes
9.4.2. Hospitals & Clinics
9.4.3. Biotechnology Company
9.4.4. Diagnostic Lab
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Targeted RNA Sequencing Market Size and Volume Forecast by Type
9.7.1. enrichment approaches
9.7.2. amplicon-based approaches
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Targeted RNA Sequencing Demand Share Forecast, 2019-2026
10. Latin America Targeted RNA Sequencing Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Targeted RNA Sequencing Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Targeted RNA Sequencing Market Size and Volume Forecast by Application
10.4.1. Research Institutes
10.4.2. Hospitals & Clinics
10.4.3. Biotechnology Company
10.4.4. Diagnostic Lab
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Targeted RNA Sequencing Market Size and Volume Forecast by Type
10.7.1. enrichment approaches
10.7.2. amplicon-based approaches
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Targeted RNA Sequencing Demand Share Forecast, 2019-2026
11. Europe Targeted RNA Sequencing Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Targeted RNA Sequencing Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Targeted RNA Sequencing Market Size and Volume Forecast by Application
11.4.1. Research Institutes
11.4.2. Hospitals & Clinics
11.4.3. Biotechnology Company
11.4.4. Diagnostic Lab
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Targeted RNA Sequencing Market Size and Volume Forecast by Type
11.7.1. enrichment approaches
11.7.2. amplicon-based approaches
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Targeted RNA Sequencing Demand Share, 2019-2026
12. Asia Pacific Targeted RNA Sequencing Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Targeted RNA Sequencing Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Targeted RNA Sequencing Market Size and Volume Forecast by Application
12.4.1. Research Institutes
12.4.2. Hospitals & Clinics
12.4.3. Biotechnology Company
12.4.4. Diagnostic Lab
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Targeted RNA Sequencing Market Size and Volume Forecast by Type
12.7.1. enrichment approaches
12.7.2. amplicon-based approaches
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Targeted RNA Sequencing Demand Share, 2019-2026
13. Middle East & Africa Targeted RNA Sequencing Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Targeted RNA Sequencing Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Targeted RNA Sequencing Market Size and Volume Forecast by Application
13.4.1. Research Institutes
13.4.2. Hospitals & Clinics
13.4.3. Biotechnology Company
13.4.4. Diagnostic Lab
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Targeted RNA Sequencing Market Size and Volume Forecast by Type
13.7.1. enrichment approaches
13.7.2. amplicon-based approaches
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Targeted RNA Sequencing Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Targeted RNA Sequencing Market: Market Share Analysis
14.2. Targeted RNA Sequencing Distributors and Customers
14.3. Targeted RNA Sequencing Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Thermo Fisher
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Illumina
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Roche Holdings
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. BGI
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Eurofins
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. LabCorp
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Berry Genomics
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Macrogen
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. GENEWIZ
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
